What You Should Know:
– GrayMatters Health (GMH), developer of non-invasive treatments based on proprietary brain biomarkers associated with mental health disorders, today announced it is expanding its U.S. footprint with additional clinics now offering Prism for PTSD™ to patients.
– Prism for PTSD is the first prescribed self-neuromodulation device, cleared by the FDA to treat post-traumatic stress disorder (PTSD) as an adjunct to standard-of-care therapies.
Expansion of Prism Treatment in PTSD Programs Across U.S. Clinics
Home Base, the largest private-sector brain health clinic in the United States specializing in Veterans, Service Members, and their families, is expanding its PTSD treatment options. The National Center of Excellence in Charlestown, Massachusetts, has integrated Prism as a supplementary treatment within its existing PTSD programs. Prism’s innovative approach is also being adopted by Fermata, a New York-based interventional psychiatry practice, to assist patients in managing PTSD symptoms more effectively. GMH is collaborating with additional clinics to further broaden access to Prism treatment in the coming months.
Prism Treatment Features and Outcomes:
– Prism utilizes a proprietary amygdala-based biomarker combined with computer simulation technology.
– Patients learn to regulate brain activity associated with PTSD symptoms, under the guidance of a trained healthcare professional.
– The pivotal trial of Prism, published in the *Journal of Psychiatry Research*, demonstrated the following outcomes:
– 67% of patients experienced clinically significant symptom improvement.
– Response rates exceeded 80% in certain sub-populations.
– A 90% compliance rate was observed, coupled with high patient satisfaction.
Safety Profile:
– Mild side effects, including headaches, dizziness, and fatigue, were reported.
– These side effects were transient and resolved post-treatment without the need for additional intervention.
“Home Base is excited to test promising new treatments, like Prism, which aim to establish gold standard PTSD treatments for Veterans, Service Members, their Families and Families of the Fallen,” said Home Base Executive Director, Retired Brig. Gen. Jack Hammond. “Providing innovative and cutting-edge options like Prism allows us to ensure our Nation’s Heroes have access to the best mental health care treatments they have earned and deserve at no out-of-pocket cost to them.”
